Research partnership to tackle degenerative and incurable diseases

TOKYO: Medical researchers in Britain and Japan are to join forces in the fight to advance research into treatments for some of the most debilitating degenerative diseases such as diabetes, heart disease and arthritis, it was confirmed today.

Prime Minister Theresa May, Business Secretary Greg Clark and Japanese Prime Minister Shinzō Abe announced a new £30 million partnership to promote new technology and innovation that could transform whole sectors and enable people to live longer, healthier lives in both countries.

The partnership includes a £10 million programme led by the UK’s Medical Research Council (MRC) and Japan’s Agency for Medical Research and Development (AMED) that will advance regenerative medicine. The research will help understanding in critical regenerative processes in human health and translate research into tools and technologies to treat patients. This could lead to new therapies for use against many types of cancer, including brain tumours or leukaemia, and repair damage caused by degenerative conditions such as motor neurone disease, Parkinson’s disease or multiple sclerosis.

British and Japanese businesses, including startups, will support this by working together to develop and showcase a new generation of assisted living products. Through a joint competition focused on employing Artificial Intelligence (AI) and robotics in assisted living, they can access funding to help create safe, ethical and intelligent home environments. Additionally, Britain will join Japan in its Well Ageing Society Summit and Global Round Table for Dementia.